It was suggested to name this material the Secondary Standard. M. Matsuda presented a proposal for a nomenclature for abnormal fibrinogen. It was decided that this nomenclature be published as an official ISTH publication. C. Francis presented a survey and comparison of the currently available assays for soluble fibrin. It is obvious that the problem of standardizing soluble fibrin is a major challenge.
Several options are under investigation.
DIC patients will be selected on very strict and specific criteria. Twelve clinicians have agreed to participate by supplying samples. The plan is to have results available in Florence in 1997 with a final report in 1998.